United States: Three Reasons Why China's New Hatch-Waxman Analog May Result In An Explosion Of Generics And Patent Litigation In China - Winston & Strawn LLP

In an Economic and Trade Agreement entered into between the governments of the U.S. and China on January 15, 2020, China committed to "establish a nationwide system for pharmaceutical products".